Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

4-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Tuesday, May 5, 2009 - 3:56pm
tags:
Abbott Laboratories
Amylin Seeks FDA Approval on Extended Byetta Treatment
WSJ Online
Tuesday, May 5, 2009 - 10:35am
tags:
Amylin, FDA, Byetta, diabetes
Amylin, Alkermes rally on FDA filing
Marketwatch
Tuesday, May 5, 2009 - 10:32am
tags:
Amylin, Alkermes, FDA
Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch
Pharma Live
Tuesday, May 5, 2009 - 9:34am
tags:
contraceptive patch, Bayer
Nycomed hopes for Daxas deal, targets IPO
Reuters
Tuesday, May 5, 2009 - 9:32am
tags:
Daxas, Nycomed, licensing, IPOs
Report: Financial Crisis could reshape biotech
Yahoo/AP
Tuesday, May 5, 2009 - 9:04am
tags:
biotech
Teva Pharmaceutical Industries' 1st-quarter profit triples on generic sales, Barr contribution
Yahoo/AP
Tuesday, May 5, 2009 - 9:01am
tags:
Teva Pharmaceuticals, earnings
FDA Calendar Updates: AstraZeneca, GlaxoSmithKline, Sanofi-Aventis
Seeking Alpha
Tuesday, May 5, 2009 - 9:00am
tags:
GSK, FDA, AstraZeneca, Sanofi
Allergan May Be Forming Handle Or Base
Yahoo/Zacks.com
Tuesday, May 5, 2009 - 6:31am
tags:
Allergan
Teva Exploring ‘Every Tool’ to Grow German Market Share
Bloomberg
Tuesday, May 5, 2009 - 6:10am
tags:
Germany, Teva Pharmaceuticals, Europe
Takeda, Lilly, Lead $28.5 Billion in Biotech Deals, Report Says
Bloomberg
Tuesday, May 5, 2009 - 6:09am
tags:
Takeda, Eli Lilly, M&A
Johnson & Johnson: Low Risk, High Value
Seeking Alpha
Tuesday, May 5, 2009 - 6:07am
tags:
JNJ
Depomed Q1 loss widens on greater revenue
Bizjournals.com
Monday, May 4, 2009 - 7:21pm
tags:
Depomed, earnings
Amylin says it will cut about 200 sales positions
Yahoo/AP
Monday, May 4, 2009 - 7:21pm
tags:
Amylin, layoffs
Vectura benefits from moving up ranks
FT.com
Monday, May 4, 2009 - 7:19pm
tags:
Vectura
Options Update: Elan Corp. Targeted by Heavy Call Buying
Schaeffers Research
Monday, May 4, 2009 - 3:18pm
tags:
Elan, H1N1
BioMarin Top-Line Diminishing
Yahoo/Zacks.com
Monday, May 4, 2009 - 3:17pm
tags:
Biomarin, earnings
United Therapeutics Awaits FDA
Yahoo/Zacks.com
Monday, May 4, 2009 - 3:16pm
tags:
United Therapeutics, FDA, Adcirca, erectile dysfunction
Beyond Provenge -- The Next Hot Cancer Drug?
Motley Fool
Monday, May 4, 2009 - 3:15pm
tags:
Provenge, Dendreon, cancer, Cell Genesys, Sanofi
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
Yahoo
Monday, May 4, 2009 - 11:12am
tags:
Pharmaxis, drug trials, cystic fibrosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.